AI tool for predicting MGMT methylation in glioblastoma for clinical decision support in resource limited settings
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
AI tool for predicting MGMT methylation in glioblastoma for clinical decision support in resource limited settings ; volume:14 ; number:1 ; day:14 ; month:11 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (14.11.2024), 1-12, 12.2024
- Creator
-
Restini, Felipe Cicci Farinha
Torfeh, Tarraf
Aouadi, Souha
Hammoud, Rabih
Al-Hammadi, Noora
Starling, Maria Thereza Mansur
Sousa, Cecília Felix Penido Mendes
Mancini, Anselmo
Brito, Leticia Hernandes
Yoshimoto, Fernanda Hayashida
Lima-Júnior, Nildevande Firmino
Queiroz, Marcello Moro
Passos, Ula Lindoso
Amancio, Camila Trolez
Takahashi, Jorge Tomio
Souza Delgado, Daniel De
Hanna, Samir Abdallah
Marta, Gustavo Nader
Neves-Junior, Wellington Furtado Pimenta
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-78189-6
- URN
-
urn:nbn:de:101:1-2502040941429.887798272609
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Restini, Felipe Cicci Farinha
- Torfeh, Tarraf
- Aouadi, Souha
- Hammoud, Rabih
- Al-Hammadi, Noora
- Starling, Maria Thereza Mansur
- Sousa, Cecília Felix Penido Mendes
- Mancini, Anselmo
- Brito, Leticia Hernandes
- Yoshimoto, Fernanda Hayashida
- Lima-Júnior, Nildevande Firmino
- Queiroz, Marcello Moro
- Passos, Ula Lindoso
- Amancio, Camila Trolez
- Takahashi, Jorge Tomio
- Souza Delgado, Daniel De
- Hanna, Samir Abdallah
- Marta, Gustavo Nader
- Neves-Junior, Wellington Furtado Pimenta
- SpringerLink (Online service)
Other Objects (12)
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma
Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Mitochondria‐Targeted Temozolomide Probe for Overcoming MGMT‐Mediated Resistance in Glioblastoma
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma
Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Mitochondria‐Targeted Temozolomide Probe for Overcoming MGMT‐Mediated Resistance in Glioblastoma
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma
Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Mitochondria‐Targeted Temozolomide Probe for Overcoming MGMT‐Mediated Resistance in Glioblastoma
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?